Huerta-Yepez, S.; Gonzalez, J.D.; Sheik, N.; Beraki, S.; Kathirvel, E.; Rodriguez-Frandsen, A.; Chen, P.-C.; Sargsyan, T.; Mahammad, S.; Dybul, M.R.;
et al. Therapeutic Efficacy of CD34-Derived Allogeneic Dendritic Cells Engineered to Express CD93, CD40L, and CXCL13 in Humanized Mouse Models of Pancreatic Cancer. Vaccines 2025, 13, 749.
https://doi.org/10.3390/vaccines13070749
AMA Style
Huerta-Yepez S, Gonzalez JD, Sheik N, Beraki S, Kathirvel E, Rodriguez-Frandsen A, Chen P-C, Sargsyan T, Mahammad S, Dybul MR,
et al. Therapeutic Efficacy of CD34-Derived Allogeneic Dendritic Cells Engineered to Express CD93, CD40L, and CXCL13 in Humanized Mouse Models of Pancreatic Cancer. Vaccines. 2025; 13(7):749.
https://doi.org/10.3390/vaccines13070749
Chicago/Turabian Style
Huerta-Yepez, Sara, Jose D. Gonzalez, Neha Sheik, Senay Beraki, Elango Kathirvel, Ariel Rodriguez-Frandsen, Po-Chun Chen, Tiran Sargsyan, Saleemulla Mahammad, Mark R. Dybul,
and et al. 2025. "Therapeutic Efficacy of CD34-Derived Allogeneic Dendritic Cells Engineered to Express CD93, CD40L, and CXCL13 in Humanized Mouse Models of Pancreatic Cancer" Vaccines 13, no. 7: 749.
https://doi.org/10.3390/vaccines13070749
APA Style
Huerta-Yepez, S., Gonzalez, J. D., Sheik, N., Beraki, S., Kathirvel, E., Rodriguez-Frandsen, A., Chen, P.-C., Sargsyan, T., Mahammad, S., Dybul, M. R., Chen, L., Binette, F., & Jewett, A.
(2025). Therapeutic Efficacy of CD34-Derived Allogeneic Dendritic Cells Engineered to Express CD93, CD40L, and CXCL13 in Humanized Mouse Models of Pancreatic Cancer. Vaccines, 13(7), 749.
https://doi.org/10.3390/vaccines13070749
